IL114673A0 - Pharmaceutical compositions containing protein - Google Patents

Pharmaceutical compositions containing protein

Info

Publication number
IL114673A0
IL114673A0 IL11467395A IL11467395A IL114673A0 IL 114673 A0 IL114673 A0 IL 114673A0 IL 11467395 A IL11467395 A IL 11467395A IL 11467395 A IL11467395 A IL 11467395A IL 114673 A0 IL114673 A0 IL 114673A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
compositions containing
containing protein
protein
pharmaceutical
Prior art date
Application number
IL11467395A
Other versions
IL114673A (en
Original Assignee
Hadasit Med Res Service
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Med Res Service filed Critical Hadasit Med Res Service
Priority to IL11467395A priority Critical patent/IL114673A/en
Publication of IL114673A0 publication Critical patent/IL114673A0/en
Priority to PCT/IL1996/000055 priority patent/WO1997003688A1/en
Priority to EP96923034A priority patent/EP0839047A1/en
Publication of IL114673A publication Critical patent/IL114673A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/26Glucagons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/28Insulins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL11467395A 1995-07-19 1995-07-19 Pharmaceutical compositions containing protein for oral administration IL114673A (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL11467395A IL114673A (en) 1995-07-19 1995-07-19 Pharmaceutical compositions containing protein for oral administration
PCT/IL1996/000055 WO1997003688A1 (en) 1995-07-19 1996-07-16 Pharmaceutical compositions containing protein
EP96923034A EP0839047A1 (en) 1995-07-19 1996-07-16 Pharmaceutical compositions containing protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11467395A IL114673A (en) 1995-07-19 1995-07-19 Pharmaceutical compositions containing protein for oral administration

Publications (2)

Publication Number Publication Date
IL114673A0 true IL114673A0 (en) 1995-11-27
IL114673A IL114673A (en) 2000-12-06

Family

ID=11067792

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11467395A IL114673A (en) 1995-07-19 1995-07-19 Pharmaceutical compositions containing protein for oral administration

Country Status (3)

Country Link
EP (1) EP0839047A1 (en)
IL (1) IL114673A (en)
WO (1) WO1997003688A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885567A (en) * 1993-10-22 1999-03-23 University Of Connecticut Treatment of infection in fowl by oral administration of avian interferon proteins
US6645485B2 (en) * 2000-05-10 2003-11-11 Allan R. Dunn Method of treating inflammation in the joints of a body
US7655618B2 (en) 2002-12-27 2010-02-02 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
US7314859B2 (en) 2002-12-27 2008-01-01 Diobex, Inc. Compositions and methods for the prevention and control of insulin-induced hypoglycemia
CN101547702B (en) 2005-09-06 2016-06-22 奥拉姆德医药公司 For oral administration method of protein and compositions
CA3083698A1 (en) 2008-03-26 2009-10-01 Oramed Ltd. Methods and compositions comprising serpin(s) for oral administration of protein
NO2300031T3 (en) 2008-05-05 2018-02-17
MX2011001313A (en) * 2008-08-04 2011-03-04 Merck Sharp & Dohme Oxazole derivatives useful as inhibitors of faah.
US9006433B2 (en) 2010-04-21 2015-04-14 Merck Sharp & Dohme Corp. Substituted pyrimidines
CN108904810A (en) 2012-01-03 2018-11-30 奥拉姆德有限公司 The method and composition for treating diabetes
CN112755002A (en) 2012-02-01 2021-05-07 奥拉姆德有限公司 Compositions containing protease inhibitors, compositions comprising the same, and methods for producing and using the same
JP6250029B2 (en) 2012-03-30 2017-12-20 ジボダン エス エー N-acyl-amino acid derivatives as food flavoring compounds
JP2016505613A (en) 2013-01-03 2016-02-25 オラムド エルティーディー. Methods and compositions for treating NAFLD, fatty liver, and its sequelae

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4476116A (en) * 1982-12-10 1984-10-09 Syntex (U.S.A.) Inc. Polypeptides/chelating agent nasal compositions having enhanced peptide absorption
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
US5167947A (en) * 1989-10-26 1992-12-01 Southwest Research Institute Enhancement of absorption of radioprotective drugs

Also Published As

Publication number Publication date
EP0839047A1 (en) 1998-05-06
WO1997003688A1 (en) 1997-02-06
IL114673A (en) 2000-12-06

Similar Documents

Publication Publication Date Title
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
HUP9602056A2 (en) Novel pharmaceutical composition containing phenofibrate
HU9601698D0 (en) Pharmaceutical composition
HUP9701554D0 (en) Pharmaceutical composition containing plazma proteins
AP9701160A0 (en) Compounds and pharmaceutical compositions containing them
ZA967827B (en) Pharmaceutical compositions
GB9519667D0 (en) Pharmaceutical composition
ZA962214B (en) Pharmaceutical composition
IL114673A0 (en) Pharmaceutical compositions containing protein
EG24294A (en) Pharmaceutical compositions
ZA963590B (en) Pharmaceutical composition
GB9506382D0 (en) Pharmaceutical compositions
GB9513972D0 (en) Pharmaceutical compositions
ZA96525B (en) Novel pharmaceutical compositions
GB9525194D0 (en) Pharmaceutical composition
ZA961051B (en) Pharmaceutical composition
ZA964193B (en) Pharmaceutical composition
HU9602822D0 (en) Pharmaceutical composition
ZA963591B (en) Pharmaceutical composition
IL110319A0 (en) Pharmaceutical compositions containing protein
HUP9602732A2 (en) Pharmaceutical composition comprising lanperisone
ZA95736B (en) Pharmaceutical composition
GB9505164D0 (en) Pharmaceutical compositions
HU0500763D0 (en) Pharmaceutical compositions
GB9519157D0 (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees